Koszty Sprzedaży Zmiana Data
Adma Biologics USD 50.4M 8.24M 2025-12
Alnylam Pharmaceuticals USD 267.72M 67.57M 2025-12
BioCryst Pharmaceuticals USD 9.52M 7.34M 2025-12
Minerva Neurosciences 386K 31K 2024-06
Novavax USD 22.1M 608K 2025-12
Omeros USD 33.16M 18.52M 2024-06
Takeda JPY 401.15B 184.07B 2025-12